Erratum: Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets (European Journal of Clinical Nutrition (2013) 67 (789-796) DOI: 10.1038/ejcn.2013.116);Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

European Journal of Clinical Nutrition

Volumn 67, Issue 8, 2013, Pages 789-796

  Paoli, A ^a   Rubini, A ^a   Volek, J S ^b   Grimaldi, K A ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

cancer; cardiovascular diseases; diabetes; ketogenic diet; neurological diseases; obesity

Indexed keywords

ACNE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; EPILEPSY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HUMAN; KETOACIDOSIS; KETOGENIC DIET; LOW CARBOHYDRATE DIET; MALIGNANT NEOPLASTIC DISEASE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PARKINSON DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; RISK REDUCTION; TRAUMATIC BRAIN INJURY; WEIGHT REDUCTION;

EID: 84881481258     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.47     Document Type: Erratum

References (109)

1. Atkins RC. Dr Atkins' Diet Revolution: The High Calorie Way to Stay Thin Forever. D. McKay Co: New York, NY, USA, 1972.
2. WHO. Medicines: Corruption and Pharmaceuticals. WHO Fact SheetWHO, 2009.
3. Veech RL. The therapeutic implications of ketone bodies: The effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 309-319.
4. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill Jr. GF. Brain metabolism during fasting. J Clin Invest 1967; 46: 1589-1595.
5. Kessler SK, Neal EG, Camfield CS, Kossoff EH. Dietary therapies for epilepsy: future research. Epilepsy Behav 2011; 22: 17-22.
6. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 243-251.
7. Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Am J Clin Nutr 2009; 90: 519-526.
8. Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Regul 1966; 4: 339-354.
9. Paoli A, Canato M, Toniolo L, Bargossi AM, Neri M, Mediati M et al. The ketogenic diet: an underappreciated therapeutic option? Clin Ter 2011; 162: e145-e153.
10. Cahill Jr. GF. Fuel metabolism in starvation. Annu Rev Nutr 2006; 26: 1-22.
11. Paoli A, Grimaldi K, Toniolo L, Canato M, Bianco A, Fratter A. Nutrition and acne: therapeutic potential of ketogenic diets. Skin Pharmacol Physiol 2012; 25: 111-117.
12. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, Soenen S, Westerterp KR. Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr 2009; 29: 21-41.
13. Feinman RD, Fine EJ. Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor Biol Med Model 2007; 4: 27.
14. Freedman MR, King J, Kennedy E. Popular diets: A scientific review. Obes Res 2001; 9(Suppl 1): 1S-40S.
15. Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 2003; 88: 1617-1623.
16. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR et al. Comparison of the atkins, zone, ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: The A TO Z weight loss study: a randomized trial. JAMA 2007; 297: 969-977.
17. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I et al. Weight loss with a low-carbohydrate, mediterranean, or low-fat diet. N Engl J Med 2008; 359: 229-241.
18. Fine EJ, Feinman RD. Thermodynamics of weight loss diets. Nutr Metab (Lond) 2004; 1: 15.
19. Halton TL, Hu FB. The effects of high protein diets on thermogenesis, satiety and weight loss: a critical review. J Am Coll Nutr 2004; 23: 373-385.
20. Paoli A, Grimaldi K, Bianco A, Lodi A, Cenci L, Parmagnani A. Medium term effects of a ketogenic diet and a mediterranean diet on resting energy expenditure and respiratory ratio. BMC Proceedings 2012 ; 6(Suppl 3): P37.
21. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al. Ketosis and appetite-mediating nutrients and hormones after weight loss. Eur J Clin Nutr 2013; e-pub ahead of print 1 May 2013; doi:10.1038/ejcn.2013.90.
22. Veldhorst M, Smeets A, Soenen S, Hochstenbach-Waelen A, Hursel R, Diepvens K et al. Protein-induced satiety: effects and mechanisms of different proteins. Physiol Behav 2008; 94: 300-307.
23. Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr 2008; 87: 44-55.
24. Paoli A, Cenci L, Fancelli M, Parmagnani A, Fratter A, Cucchi A et al. Ketogenic diet and phytoextracts comparison of the efficacy of mediterranean, zone and tisanoreica diet on some health risk factors. Agro Food Ind Hi-Tech 2010; 21: 24.
25. Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy Jr. WS, Brehm BJ et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-Analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285-293.
26. Blackburn GL, Phillips JC, Morreale S. Physician's guide to popular lowcarbohydrate weight-loss diets. Cleve Clin J Med 2001; 68: 761-766768-9, 773-4.
27. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2009; 44: 297-309.
28. Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gomez AL, Scheett TP et al. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr 2002; 132: 1879-1885.
29. Volek JS, Sharman MJ, Forsythe CE. Modification of lipoproteins by very low-carbohydrate diets. J Nutr 2005; 135: 1339-1342.
30. Jornayvaz FR, Samuel VT, Shulman GI. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr 2010; 30: 273-290.
31. Hellerstein MK. De novo lipogenesis in humans: Metabolic and regulatory aspects. Eur J Clin Nutr 1999; 53(Suppl 1): S53-S65.
32. Bistrian BR, Blackburn GL, Flatt JP, Sizer J, Scrimshaw NS, Sherman M. Nitrogen metabolism and insulin requirements in obese diabetic adults on a proteinsparing modified fast. Diabetes 1976; 25: 494-504.
33. Gumbiner B, Wendel JA, McDermott MP. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1996; 63: 110-115.
34. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005; 142: 403-411.
35. Dashti HM, Al-Zaid NS, Mathew TC, Al-Mousawi M, Talib H, Asfar SK et al. Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol Cell Biochem 2006; 286: 1-9.
36. Yancy Jr. WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005; 2: 34.
37. Nielsen JV, Joensson EA. Low-carbohydrate diet in type 2 diabetes: Stable improvement of bodyweight and glycemic control during 44 months follow-up. Nutr Metab (Lond) 2008; 5: 14.
38. Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PLoS One 2013; 8: e57873.
39. Hartman AL, Gasior M, Vining EP, Rogawski MA. The neuropharmacology of the ketogenic diet. Pediatr Neurol 2007; 36: 281-292.
40. McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 2011; 52: e7-e11.
41. Hartman AL, Lyle M, Rogawski MA, Gasior M. Efficacy of the ketogenic diet in the 6-hz seizure test. Epilepsia 2008; 49: 334-339.
42. Kossoff E. The fat is in the fire: ketogenic diet for refractory status epilepticus. Epilepsy Curr 2011; 11: 88-89.
43. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA et al. Origins and evolution of the western diet: health implications for the 21st century. Am J Clin Nutr 2005; 81: 341-354.
44. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. The effect of a highprotein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: A randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247-256.
45. Smith R, Mann N. Acne in adolescence: a role for nutrition? Nutr Diet 2007; 64: S147-S149.
46. Cordain L. Implications for the role of diet in acne. Semin Cutan Med Surg 2005; 24: 84-91.
47. Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids 1997; 62: 258-265.
48. Goodman-Gruen D, Barrett-Connor E. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The rancho bernardo study. Diabetes Care 1997; 20: 645-649.
49. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PD. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 1991; 266: 18868-18876.
50. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B et al. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-Activated insulin receptors. Mol Cell Biol 2007; 27: 3569-3577.
51. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA et al. Diabetes and cancer: a consensus report. CA Cancer J Clin 2010; 60: 207-221.
52. Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr Relat Cancer 2012; 19: R225-R241.
53. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17: 328-336.
54. AA.VV. Research in cancer. Science 1925; 62: x;xiixiv.
55. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927; 8: 519-530.
56. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
57. Warburg O. On respiratory impairment in cancer cells. Science 1956; 124: 269-270.
58. Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS et al. Mitochondrial respiration defects in cancer cells cause activation of akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006; 175: 913-923.
59. Sandri M, Barberi L, Bijlsma AY, Blaauw B, Dyar KA, Milan G et al. Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1- akt-mTOR-FoxO pathway. Biogerontology 2013; e-pub ahead of print 19 May 2013.
60. Schwertfeger KL, McManaman JL, Palmer CA, Neville MC, Anderson SM. Expression of constitutively activated akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J Lipid Res 2003; 44: 1100-1112.
61. Klement RJ, Kammerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutr Metab (Lond) 2011; 8: 75.
62. Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 1987; 56: 39-43.
63. Beck SA, Tisdale MJ. Effect of insulin on weight loss and tumour growth in a cachexia model. Br J Cancer 1989; 59: 677-681.
64. Ho VW, Leung K, Hsu A, Luk B, Lai J, Shen SY et al. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 2011; 71: 4484-4493.
65. Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer 2008; 8: 122.
66. Seyfried BT, Kiebish M, Marsh J, Mukherjee P. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther 2009; 5(Suppl 1): S7-S15.
67. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 2007; 4: 5.
68. Schmidt M, Pfetzer N, Schwab M, Strauss I, Kammerer U. Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: a pilot trial. Nutr Metab (Lond) 2011; 8: 54.
69. Nebeling LC, Lerner E. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc 1995; 95: 693-697.
70. Nebeling LC, Miraldi F, Shurin SB, Lerner E. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: Two case reports. J Am Coll Nutr 1995; 14: 202-208.
71. Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 2012; 28: 1028-1035.
72. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group. Fertil Steril 2012; 97: 28-38. e25.
73. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005; 83: 1454-1460.
74. Tosi F, Negri C, Perrone F, Dorizzi R, Castello R, Bonora E et al. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2012; 97: 1712-1719.
75. Blank SK, McCartney CR, Chhabra S, Helm KD, Eagleson CA, Chang RJ et al. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. J Clin Endocrinol Metab 2009; 94: 2360-2366.
76. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 1996; 81: 881-886.
77. Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a lowcarbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond) 2005; 2: 35.
78. Baranano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol 2008; 10: 410-419.
79. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012; 3: 59.
80. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48: 43-58.
81. Huffman J, Kossoff EH. State of the ketogenic diet(s) in epilepsy. Curr Neurol Neurosci Rep 2006; 6: 332-340.
82. Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley TJ, Pfender RM et al. 2-deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 2006; 9: 1382-1387.
83. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009; 59: 293-315.
84. Palop JJ, Mucke L. Epilepsy and cognitive impairments in alzheimer disease. Arch Neurol 2009; 66: 435-440.
85. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F et al. Amyloid-beta/fyninduced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer's disease. J Neurosci 2011; 31: 700-711.
86. Noebels J. A perfect storm: converging paths of epilepsy and alzheimer's dementia intersect in the hippocampal formation. Epilepsia 2011; 52(Suppl 1): 39-46.
87. Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and alzheimer's disease. Lancet Neurol 2011; 10: 187-198.
88. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate alzheimer's disease: A randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009; 6: 31.
89. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-betahydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 5440-5444.
90. Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of alzheimer's disease. Nutr Metab (Lond) 2005; 2: 28.
91. Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology 2005; 64: 728-730.
92. Prins ML, Fujima LS, Hovda DA. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J Neurosci Res 2005; 82: 413-420.
93. Appelberg KS, Hovda DA, Prins ML. The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. J Neurotrauma 2009; 26: 497-506.
94. Schwartzkroin PA, Wenzel HJ, Lyeth BG, Poon CC, Delance A, Van KC et al. Does ketogenic diet alter seizure sensitivity and cell loss following fluid percussion injury? Epilepsy Res 2010; 92: 74-84.
95. Siva N. Can ketogenic diet slow progression of ALS? Lancet Neurol 2006; 5: 476.
96. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J et al. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 2006; 7: 29.
97. Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: A 6-month prospective observational study. Clin Nutr 2012; 31: 246-249.
98. Sabapathy S, Morris NR, Schneider DA. Ventilatory and gas-exchange responses to incremental exercise performed with reduced muscle glycogen content. J Sci Med Sport 2006; 9: 267-273.
99. Jia Y, Hwang SY, House JD, Ogborn MR, Weiler HA, O K et al. Long-term high intake of whole proteins results in renal damage in pigs. J Nutr 2010; 140: 1646-1652.
100. Wakefield AP, House JD, Ogborn MR, Weiler HA, Aukema HM. A diet with 35% of energy from protein leads to kidney damage in female sprague-dawley rats. Br J Nutr 2011 1-8.
101. Skov AR, Haulrik N, Toubro S, Molgaard C, Astrup A. Effect of protein intake on bone mineralization during weight loss: A 6-month trial. Obes Res 2002; 10: 432-438.
102. Martin WF, Armstrong LE, Rodriguez NR. Dietary protein intake and renal function. Nutr Metab (Lond) 2005; 2: 25.
103. Welle S, Nair KS. Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 1990; 258: E990-E998.
104. Praga M. Synergy of low nephron number and obesity: A new focus on hyperfiltration nephropathy. Nephrol Dial Transplant 2005; 20: 2594-2597.
105. Eisenstein J, Roberts SB, Dallal G, Saltzman E. High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiologic data. Nutr Rev 2002; 60: 189-200.
106. Westerterp-Plantenga MS. How are normal, high- or low-protein diets defined? Br J Nutr 2007; 97: 217-218.
107. Pijls LT, de Vries H, Donker AJ, van Eijk JT. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: A randomized trial. Nephrol Dial Transplant 1999; 14: 1445-1453.
108. Pijls LT, de Vries H, van Eijk JT, Donker AJ. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr 2002; 56: 1200-1207.
109. Poplawski MM, Mastaitis JW, Isoda F, Grosjean F, Zheng F, Mobbs CV. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One 2011; 6: e18604.